MONTRÉAL, 10 janv. 2023 (GLOBE NEWSWIRE) — Redevances Aurifères Osisko Ltée (la « Société » ou « Osisko ») (TSX et NYSE : OR) a le plaisir de fournir une mise à jour sur ses livraisons, ses ventes et sa marge monétaire du quatrième trimestre…
In December 2023 Enefit Green’s total energy generation from renewable sources and municipal waste reached a total volume of 177.7 GWh – 114.4 GWh of it electricity and 63.3 GWh heat energy. Enefit Green produced 114.4 GWh electricity during December…
Portland, OR, Jan. 11, 2023 (GLOBE NEWSWIRE) — According to the report published by Allied Market Research, the global metal roofing market generated $23.8 billion in 2020, and is estimated to reach $33.5 billion by 2030, witnessing a CAGR of…
Esta especialización demuestra nuestra experiencia en la evaluación, diseño, implementación y optimización de la infraestructura de escritorio virtual en Azure ATLANTA, BENGALURU, India y LONDRES, 11 de enero de 2023 /PRNewswire/ — Microland, líder mundial en transformación digital, ha anunciado hoy…
MONTRÉAL, Jan. 10, 2023 (GLOBE NEWSWIRE) — Osisko Gold Royalties Ltd (the “Corporation” or “Osisko”) (OR: TSX & NYSE) is pleased to provide an update on its fourth quarter 2023 deliveries, sales and cash margins, as well as a recap…
Record Nine Month Net Sales of $339.2 millionNine Month Net Income of $7.7 million BOCA RATON, Fla., Jan. 10, 2023 (GLOBE NEWSWIRE) — Q.E.P. CO., INC. (OTCQX: QEPC) (the “Company” or “QEP”) today reported its consolidated results of operations for…
COPENHAGEN, Denmark, Jan. 11, 2023 /PRNewswire/ — SNIPR BIOME ApS, a leading CRISPR and microbiome biotechnology company, is pleased to announce that the US Food and Drug Administration (FDA) has approved the Investigational New Drug (IND) Application, for our first development…
WAYNE, Pa. and ROCKVILLE, Md., Jan. 10, 2023 (GLOBE NEWSWIRE) — Avalo Therapeutics, Inc. (Nasdaq: AVTX) (“Avalo” or the “Company”), a leading clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical need…
IRVINE, Calif., Jan. 10, 2023 (GLOBE NEWSWIRE) — Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today reported preliminary unaudited fourth quarter…
“Nuestra misión siempre ha sido hacer que la vida de las personas sea mejor y más saludable, y estamos muy contentos de mostrar nuestras últimas innovaciones y diseños en CES 2023 y en línea”, dijo Rodney Ryu, el Director General…
